Psychiatry and Neurology, Neurology · Pollocksville, NC
NPI
1700836681
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
137 Medical Lane
Pollocksville, NC, 28573
Phone (252) 633-1010
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
8,989 services
Medicare patients, 2024
731
Average age 73
Drug cost, 2024
$1.2M
5,825 prescriptions
Company payments, 2025
$43.91
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Champey was code 99214 (office e&m - established), 792 times for 562 patients. In total Daniel R Champey billed 8,989 services in 38 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 792 | 562 | $82.94 | $66K |
| 96372 Injection Administration | Office | 233 | 51 | $8.22 | $1,915 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 214 | 38 | $0.76 | $164 |
| 99204 Office E&M - New | Office | 152 | 152 | $103.19 | $16K |
| 82607 Clinical Chemistry | Office | 97 | 96 | $14.78 | $1,434 |
| 82746 Clinical Chemistry | Office | 93 | 93 | $14.41 | $1,340 |
| 84443 Clinical Chemistry | Office | 90 | 90 | $16.46 | $1,481 |
| 93040 Electrocardiogram | Office | 71 | 71 | $8.02 | $569 |
| 95910 Electrical Nerve Conductivity | Office | 68 | 67 | $87.76 | $5,968 |
| 36415 Venipuncture Blood Collection | Office | 65 | 63 | $8.65 | $562 |
| 95816 Neurologic | Office | 62 | 62 | $232.56 | $14K |
| 95885 Electrical Nerve Conductivity | Office | 59 | 59 | $28.91 | $1,706 |
| 70450 CT/CTA - Head and Neck | Office | 59 | 58 | $46.30 | $2,732 |
| 95886 Electrical Nerve Conductivity | Office | 34 | 32 | $45.92 | $1,561 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 30 | 13 | $0.36 | $10.91 |
By year: 2022 $186K for 9,129 services; 2023 $181K for 5,577 services; 2024 $133K for 8,989 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82607 Clinical Chemistry | 97 | 96 | $14.78 | $1,434 |
| 82746 Clinical Chemistry | 93 | 93 | $14.41 | $1,340 |
| 84443 Clinical Chemistry | 90 | 90 | $16.46 | $1,481 |
| 36415 Venipuncture Blood Collection | 65 | 63 | $8.65 | $562 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Champey prescribed most often to Medicare patients was Donepezil Hcl, with 534 prescriptions and refills. In total Daniel R Champey wrote 5,825 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 534 | 1,088 | 133 | $12K |
| Gabapentin Generic | 428 | 885 | 104 | $10K |
| Levetiracetam Generic | 323 | 560 | 59 | $11K |
| Primidone Generic | 299 | 564 | 68 | $5,945 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 285 | 574 | 68 | $10K |
| Clonazepam Generic | 266 | 407 | 57 | $3,615 |
| Lamotrigine Generic | 231 | 427 | 43 | $3,885 |
| Cyclobenzaprine Hcl Generic | 215 | 243 | 59 | $4,806 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 203 | 379 | 50 | $7,396 |
| Topiramate Generic | 194 | 421 | 50 | $1,648 |
| Divalproex Sodium Er Divalproex Sodium | 164 | 358 | 51 | $10K |
| Carbamazepine Er Carbamazepine | 139 | 202 | 24 | $14K |
| Pregabalin Generic | 132 | 219 | 26 | $3,249 |
| Memantine Hcl Generic | 130 | 274 | 40 | $4,240 |
| Clopidogrel Clopidogrel Bisulfate | 128 | 269 | 29 | $1,172 |
Brand drugs: 477 claims; generic drugs: 5,315 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel R Champey $43.91 ($43.91 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $23.28.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.